This Article 
 Bibliographic References 
 Add to: 
Privacy Interests in Prescription Data, Part I: Prescriber Privacy
January/February 2009 (vol. 7 no. 1)
pp. 72-76
Patricia Kosseim, Genome Canada
Khaled El Emam, Children's Hospital of Eastern Ontario
For several years, concern has been growing about privacy implications that arise from using and disclosing prescription data. Some patterns or practices provide pharmaceutical companies with the historical trends they need to better target their marketing efforts aimed at individual physicians through more intense, precise, and unique detailing strategies. In the first of a two part-article, the authors focus the privacy implications arising from the sale or transfer of prescription data, in respect to prescribers in Canada and the US.

1. A. Wazana, "Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?" J. Am. Medical Assoc., vol. 283, no. 3, 2000, pp. 373–380.
2. R. Adair and L. Holmgren, "Do Drug Samples Influence Resident Prescribing Behavior? A Randomized Trial," Am. J. Medicine, vol. 118, 2005, pp. 881–884.
3. H. Prosser, S. Almond, and T. Walley, "Influences on GPs' Decision to Prescribe New Drugs—The Importance of Who Says What," Family Practice, vol. 20, no. 1, 2003, pp. 61–68.
4. P. Manchanda and E. Honka, "The Effects and Role of Direct-to-Physician Marketing in the Pharmaceutical Industry: An Integrative Review," Yale J. Health Policy, Law and Ethics, vol. 5, 2005, pp. 785–809.
5. "Privacy Commissioner Releases His Finding on the Prescribing Patterns of Doctors," PIPEDA Case Summary #15,2 Oct. 2001;
6. IMS Health Canada Limited v. Alberta (Information and Privacy Commissioner), 2008 ABQB 213 (Alberta Court of Queen's Bench); en/ ab/ abqb/ doc/ 2008/2008abqb2132008abqb213.html.
7. Prescription Information Law, New Hampshire Revised Statutes Annotated, 2006, sections 318, 47-f, 47-g, and B:12.
8. IMS Health Incorporated et al. v. Kelly Ayotte, Federal Supplement, 2nd Series, vol. 490, 2007, p. 163 (US District Court for New Hampshire);
9. IMS Health Inc. and Verispan LLC v. Kelly A. Ayotte and the New Hampshire Attorney General, 2008 (US Court of Appeals for the First Circuit);
10. An Act to Amend the Prescription Privacy Law, Maine Revised Statutes Annotated, vol. 22, 2007, chapter 460, sections 1711-E, 8704, and 8713.
11. IMS Health Inc. et al. v. G. Steven Rowe, Attorney General for the State of Maine, Federal Supplement, 2nd Series, vol. 163, 2007, p. 153 (US District Court of Maine); jaw_01022008_1-07-cv127_ims_v_maine.pdf.

Index Terms:
prescription data, privacy laws, pharmaceutical data, privacy, privacy interests
Patricia Kosseim, Khaled El Emam, "Privacy Interests in Prescription Data, Part I: Prescriber Privacy," IEEE Security & Privacy, vol. 7, no. 1, pp. 72-76, Jan.-Feb. 2009, doi:10.1109/MSP.2009.14
Usage of this product signifies your acceptance of the Terms of Use.